Biomarker Accelerator Program supports researchers pursuing biomarker discoveries for progressive supranuclear palsy to accelerate diagnosis, treatment, research, or clinical care.
Biomarker Accelerator Grant Program supports researchers translating and validating existing PSP biomarkers for research and clinical use, aiming to improve diagnosis, monitoring and treatment-response assessment.
Parkinson's Disease Biomarker Innovation and Advancement Program supports teams developing fluid- and imaging-based biomarkers for clinical implementation and broader use in Parkinson's research.
The Rainwater Charitable Foundation’s Medical Research Program funds innovative research on tauopathies, supporting studies that advance understanding and treatment of tau-related neurodegenerative diseases.
The CURE SYNGAP1 Grants Program funds research to advance clinical trial readiness and treatment development for SYNGAP1-Related Disorders.
Milestones to a Cure supports independent investigators pursuing bold mechanistic, clinical, and translational research to overcome scientific barriers to durable remission and a cure for psoriatic disease.